Article
NS5A inhibitor resistance-associated polymorphisms in Brazilian treatment-naive patients infected with genotype 1 hepatitis C virus.
The Journal of antimicrobial chemotherapy - 1 Mar 2015
Peres-da-Silva Allan, de Almeida Adilson José, Lampe Elisabeth
Abstract excerpt
OBJECTIVES: Several promising NS5A protein inhibitors for hepatitis C virus (HCV) treatment, showing good antiviral activity, are currently being evaluated in clinical trials. However, viral breakthroughs associated with resistant variants have been observed, especially in patients infected with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
